Broad Institute is empowering a revolution in biomedicine to accelerate the pace at which the world conquers disease
Propelling the understanding and treatment of disease
Collaborating deeply
Broad Institute is a mission-driven community that brings together researchers in medicine, biology, chemistry, computation, engineering, and mathematics from across MIT, Harvard, and Harvard-affiliated hospitals, along with collaborators around the world
Reaching globally
Broad Institute is committed to addressing medical challenges across the world, including collaborating with scientists and public health experts to address important needs in developing countries
Empowering scientists
Broad Institute fosters an environment in which scientists can take risks on bold ideas with transformative potential
Building partnerships
Broad Institute works to build and sustain international consortia to speed discovery in areas including psychiatric research, infectious disease, cardiovascular disease, and cancer
Promoting inclusion
Broad Institute believes that progress in biomedical research requires a fully inclusive community across sex, race, ethnicity, sexual orientation, age, and gender identity
INSIDE BROAD
News / 12.11.18
Mutations in TTN, a gene associated with several forms of heart disease and heart failure, may also play key roles in early form of a common heart arrhythmia.Read more
News / 12.10.18
Biopsies taken before and after treatment reveal new resistance route, as well as an opportunity to resensitize breast tumors to therapy.Read more
News / 11.28.18
By analyzing the DNA of more than 55,000 people, an international team of researchers identify 12 regions of the genome that raise the risk of ADHD, providing valuable biological insights.Read more
News / 11.26.18
The following is a statement by core institute member Feng Zhang in response to reports that a researcher in China has engineered the “world’s first genetically edited babies.” Zhang’s team pioneered...Read more
News / 11.7.18
Online tool can help researchers correct pathogenic mutations and restore genes to healthy stateRead more
News / 11.5.18
Using a new model dubbed DEMETER2, the Broad's Cancer Dependency Map team has compiled the largest dataset of genetic dependencies in cancer to date.Read more
News / 11.2.18
Laboratory study suggests that thalidomide-like drugs could be designed to target a broad array of transcription factors, and open a new landscape of cancer drug development.Read more
News / 11.1.18
Researchers identify a molecular strategy that human melanoma cells use to resist immunotherapy, and develop a new approach to combat the resistance in mouse modelsRead more
News / 11.1.18
A subset of intestinal stem cells communicate with T helper cells, which in turn may influence stem cells' state through the cytokines they produce.Read more
Spotlight / 12.6.18
A new video produced by the McGovern Institute and the Broad depicts how CRISPR-Cas9 can be programed to detect human disease, demonstrating its potential to transform global health.Read more
News / 11.9.18
Temporary art installation and public talk by Broad artist-in-residence alumna Guhapriya Ranganathan will be held on November 16 at the Broad Institute.Read more
Blog / 11.7.18
In a #WhyIScience Q&A, Samantha Baxter, one of Broad’s in-house genetic counselors, describes her role in the evolving field of clinical genomicsRead more